PathAI Digital Pathology AI
by Nick Clark | Published April 25, 2026
PathAI operates major commercial digital-pathology AI platform across pharmaceutical clinical-trial and clinical-diagnostic customers. Architectural element — depth-selective gradient routing — is what training-governance provides.
PathAI Reality
PathAI operates AI-augmented pathology platform with substantial pharmaceutical clinical-trial customer engagement and emerging clinical-diagnostic deployment.
Training-Governance Substrate
PathAI training operations operate as credentialed observations; per-example provenance supports FDA-relevant audit.
PathAI Position
PathAI gains FDA-aligned architectural substrate.
